Unknown

Dataset Information

0

Fluid type and volume reduce risk of post-ERCP pancreatitis and length of hospital stay in high-risk patients: a secondary analysis of the INDIEH trial.


ABSTRACT: Background and study aims? Impact of intravenous fluid administration on prophylaxis against post-endoscopic retrograde cholangiopancreatography pancreatitis (PEP) has not been rigorously evaluated among patients at high-risk for PEP. Patients and methods? Effect of volume and type of fluid administered on PEP incidence was studied through a secondary analysis of high-risk patients who underwent endoscopic retrograde cholangopancreatography (ERCP) as a part of a randomized controlled trial in which all patients received rectal indomethacin. Periprocedural fluid was defined as fluid infused during and after ERCP. Results? A total 960 patients were randomized during the trial, of whom 476 (49.6?%) received periprocedural fluids (mean volume?=?1245?mL [±?629]). There was a trend towards a lower incidence of PEP in patients who received periprocedural fluid vs. those who did not (5.2?% vs. 8.0?%, P ?=?0.079). Among those receiving fluids, those who did not develop PEP received a higher mean volume of fluid vs. who developed PEP (1012?±?725?mL vs. 752?±?783?mL, P ?=?0.036). Among 174 patients (37?%) who received LR, patients who did not develop PEP received a higher mean volume of LR vs. those who developed PEP (570?±?559?mL vs. 329?±?356?mL, P ?=?0.006). Length of hospital stay decreased as the volume of periprocedural volume administration increased (r?=?0.16, P ?

SUBMITTER: Talukdar R 

PROVIDER: S-EPMC7359859 | biostudies-literature | 2020 Jul

REPOSITORIES: biostudies-literature

altmetric image

Publications


<b>Background and study aims </b> Impact of intravenous fluid administration on prophylaxis against post-endoscopic retrograde cholangiopancreatography pancreatitis (PEP) has not been rigorously evaluated among patients at high-risk for PEP. <b>Patients and methods </b> Effect of volume and type of fluid administered on PEP incidence was studied through a secondary analysis of high-risk patients who underwent endoscopic retrograde cholangopancreatography (ERCP) as a part of a randomized controll  ...[more]

Similar Datasets

| S-EPMC8046183 | biostudies-literature
| S-EPMC8453321 | biostudies-literature
| S-EPMC4024015 | biostudies-other
| 72433 | ecrin-mdr-crc
| S-EPMC1950279 | biostudies-other
| S-EPMC3229993 | biostudies-literature
| S-EPMC4968081 | biostudies-literature
| S-EPMC5014656 | biostudies-literature
| S-EPMC5565843 | biostudies-literature
| S-EPMC1184244 | biostudies-literature